Long-term Safety and Efficacy Extension Study Data of ALPROLIX, Extended Half-life Treatment for Haemophilia B Patients
Alprolix is the new extended half life treatment that will be available to haemophilia B patients in Ireland from April 2017. Alprolix will allow patients to infuse less frequently …